UNASSIGNED: @entity438 are rare with an incidence of less than 0.8%. Evidence to support an endovascular management strategy over open surgical repair for @entity5475 is limited. We used the Nationwide Inpatient Sample to compare open to endovascular @entity5475 repair by assessing postoperative outcomes, length of hospital stay, and mortality. Multivariate logistic regression analysis was done to determine predictors of @entity260 . There were 2316 admissions with a diagnosis code for @entity5475 [347 (14.9%) endovascular repair and 112 (4.8%) open surgery]. There was a statistically significant lower rate of cardiac (2.3% vs 6.9%, P   =   0.05) and pulmonary (8.9% vs 16.1%, P   =   0.05) complications for the endovascular repair group. The risk of @entity281 was also lower (0.6% vs 5.1%, P   =   0.01) in the endovascular group. Median in-hospital LOS was greater for open repairs (6 vs. 4 days, P   =   0.01). There were no statistically significant differences across procedures for @entity8 (8.9%, P   =   0.88) or in-hospital mortality (3%, P   =   0.99). Regression analysis established procedure type to be independent predictor of @entity260 . Endovascular repair of @entity5475 is therefore associated with a lower complication rate and less resource utilization but no difference in mortality peri-operatively. This may justify an endovascular first treatment strategy in the management of @entity5475 .

A comparison of open and endovascular treatment strategies for the management of XXXX .

@entity8 :: ('MESH:D007674', 'Disease') :: ['renal complications'] @entity260 :: ('MESH:D011183', 'Disease') :: ['postoperative complications'] @entity281 :: ('MESH:D007239', 'Disease') :: ['surgical site infection'] @entity5475 :: ('6287', 'Gene') :: ['SAA'] @entity438 :: ('MESH:D002532', 'Disease') :: ['Splenic artery aneurysms']
@entity438 :: (MESH:D002532,Disease) :: ['splenic artery aneurysms']
